Trial Profile
The tolerability of trastuzumab + docetaxel versus docetaxel monotherapy in patients with HER-2 positive breast cancer in France
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Docetaxel
- Indications Breast cancer; HER2 positive breast cancer
- Focus Adverse reactions
- 02 May 2014 New trial record